Tactile Systems: A Little Less Miserable

Tactile Systems Technology (TCMD +17.54%) had a good day. Not a good good day, mind you. Just…less bad. The stock went up nearly 18%. In the grand scheme of things, that’s a blip. But people noticed. So it goes.

A Bit of Revenue

They published their fourth quarter and full-year 2025 numbers on Tuesday. Revenue was up 21% to $103.6 million. Net income, as calculated by accountants who must eat too, rose 9% to $10.6 million ($0.46 a share). It’s all just numbers, really. Attempts to quantify the unquantifiable.

Analysts, those brave souls who try to predict the future, expected less. They figured around $94 million in revenue and $0.44 a share. They were wrong. Which proves, mostly, that they’re human.

A lot of the increase came from airway clearance products – up 66%. People are clearing their airways. It’s a good thing, I suppose. Also, sales and rentals of lymphedema devices rose 16%. Lymphedema. A sad little condition. But business is business.

Loading widget...

Looking Ahead (Sigh)

They’re predicting revenue will grow another 8% to 11% in 2026, hitting $357 million to $365 million. Adjusted EBITDA should land between $49 million and $51 million. It’s all projection, of course. A hopeful story we tell ourselves. Last year it was $44.8 million. Progress, maybe. Or just a different kind of sadness.

I don’t see much to complain about, honestly. They’ve found a few niches where people are willing to spend money. And the medical device market? It’ll keep growing, because people keep getting older, and more broken. So it goes. I’d consider buying the stock. Not because it’s a sure thing – nothing is – but because, well, why not? We all need something to distract us from the inevitable.

Read More

2026-02-19 03:22